Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital...
16 insider purchases on record · latest filing 2024-12-31.
Insiders have also filed 74 sale transactions at ASMB.